Semaglutide + B12
FDA-class GLP-1 receptor agonist for weight management. Same-day telehealth consultation, compounded with B12 for enhanced results.
Start Your VisitClinical Overview
Semaglutide is a GLP-1 receptor agonist that has demonstrated significant efficacy in weight management. It mimics the incretin hormone GLP-1, increasing feelings of fullness and reducing hunger. Our formulation is compounded with Vitamin B12 to support energy metabolism.
Clinical Safety Framing: Risk, contraindications, interactions, and follow-up planning should be reviewed before initiating any peptide pathway.
Key Benefits
Appetite Regulation — reduces cravings through CNS GLP-1 activation
Metabolic Support — improves insulin sensitivity and glucose metabolism
Sustained Results — weekly injection with progressive dose titration
B12 Enhancement — combats fatigue during caloric restriction
Frequently Asked Questions
How quickly will I see results?
Most patients notice reduced appetite within 1-2 weeks. Clinically meaningful weight loss typically appears within 4-8 weeks.
What makes this different from Ozempic?
Our semaglutide is compounded with B12 by state-licensed 503A pharmacies. Same active ingredient, enhanced formulation.
Clinical References & Policies
Global Disclaimer: This content is educational and does not replace individualized medical advice. Treatment decisions should be made with a licensed clinician based on personal history, risk profile, and appropriate monitoring.
Medical Disclaimer: Information provided is for educational purposes only and does not constitute medical advice. All therapies require a consultation with a licensed clinician. Individual results may vary. Compounded medications are prepared by state-licensed 503A pharmacies and are not FDA-approved.
Ready to Get Started?
Same-day telehealth consultation with a licensed clinician.
Start Your Visit